Long-term Persistence of Hepatitis A Immunity in Healthy Adults Vaccinated as Part of a Hepatitis A Universal Mass Vaccination Program
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2018
Price : $35 *
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 01 Mar 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Dec 2017 Planned End Date changed from 10 May 2018 to 28 Jan 2019.
- 29 Dec 2017 Planned primary completion date changed from 10 May 2018 to 28 Jan 2019.